Kinase Inhibitor News and Research

RSS
A protein kinase inhibitor is a type of enzyme inhibitor that specifically blocks the action of one or more protein kinases.
Still-to-be-approved drug proves to be new option for treating active rheumatoid arthritis

Still-to-be-approved drug proves to be new option for treating active rheumatoid arthritis

Researchers discover unique approach to treat some chronic inflammatory diseases

Researchers discover unique approach to treat some chronic inflammatory diseases

Scientists use a promiscuous inhibitor to uncover cancer drug targets

Scientists use a promiscuous inhibitor to uncover cancer drug targets

FDA extends indication of metastatic breast cancer treatment to include male patients

FDA extends indication of metastatic breast cancer treatment to include male patients

Understanding maintenance of quiescent stem cells in chronic myelogenous leukemia

Understanding maintenance of quiescent stem cells in chronic myelogenous leukemia

New research finds how cancer cells acquire resistance to molecular-targeted drugs

New research finds how cancer cells acquire resistance to molecular-targeted drugs

Researchers discover origin of resistance to lung cancer

Researchers discover origin of resistance to lung cancer

Bio-Rad launches new digital PCR system and kit for monitoring treatment response in CML patients

Bio-Rad launches new digital PCR system and kit for monitoring treatment response in CML patients

Researchers identify promising therapeutic option to treat multiple sclerosis

Researchers identify promising therapeutic option to treat multiple sclerosis

New drug combination could kill melanoma cells more effectively, study shows

New drug combination could kill melanoma cells more effectively, study shows

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Study offers new hope to patients with rare brain cancer

Study offers new hope to patients with rare brain cancer

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Survey: Physicians need more information to assess impact of NSCLC treatment sequencing

Survey: Physicians need more information to assess impact of NSCLC treatment sequencing